Skip to main content
Top
Published in: Pathology & Oncology Research 3/2015

01-07-2015 | Research

The Role of MRI in the Assessment of the Local Status of Anal Carcinomas and in Their Management

Authors: É. Jederán, J. Lővey, Z. Szentirmai, E. Hitre, G. Léránt, K. Horváth, M. Gődény

Published in: Pathology & Oncology Research | Issue 3/2015

Login to get access

Abstract

This study aims to define the role of Magnetic Resonance (MR) examinations in the assessment and therapy of anal cancer (AC), and to present the main features of the MR examinations and the typical tumor spread pattern. The MR examinations of 67 anal cancer patients with histologically confirmed planocellular cancer were analyzed retrospectively. The tumor size and the signal intensity, the nodal status were examined before and after the treatment, and in recidive tumors (N = 13). At the time of the diagnosis the primary tumor was in early stage (Tis, T1, T2) in 71.5 % of the cases, and it was localized in 97 %. In 97.4 % of the cases the tumor had relatively increased signal intensities compared to the adjacent muscles. Patients received chemo-radiotherapy (CRT). After CRT in 26 out of 39 patients (66.7 %) the size of the tumor decreased (in 75 %), and the signal intensity decreased on the T2 weighted (T2w) images. In the residual tumor cases (19/39) verified 6 patients out of 19 had further decrease in size, and signal intensity a year after the end of the therapy. The MR examination plays a key role in the therapy of AC, by assessing the precise local status, the possible recidive tumors, and monitoring the therapy.
Literature
1.
go back to reference Clark MA, Hartley A, Geh JI (2004) Cancer of the anal canal. Lancet Oncol 3:149–157CrossRef Clark MA, Hartley A, Geh JI (2004) Cancer of the anal canal. Lancet Oncol 3:149–157CrossRef
2.
go back to reference Deans GT, McAleer JJ, Spence RA (1994) Malignant anal tumours. Br J Surg 4:500–508CrossRef Deans GT, McAleer JJ, Spence RA (1994) Malignant anal tumours. Br J Surg 4:500–508CrossRef
3.
go back to reference Licitra L, Spinazzé S, Doci R, Evans TR, Tanum G, Ducreux M (2002) Cancer of the anal region. Crit Rev Oncol Hematol 1:77–92CrossRef Licitra L, Spinazzé S, Doci R, Evans TR, Tanum G, Ducreux M (2002) Cancer of the anal region. Crit Rev Oncol Hematol 1:77–92CrossRef
4.
go back to reference Kásler M (ed) (2011) Az onkológia alapjai. Medicina Könyvkiadó Rt, Budapest Kásler M (ed) (2011) Az onkológia alapjai. Medicina Könyvkiadó Rt, Budapest
5.
go back to reference Fuchshuber PR, Rodriguez-Bigas M, Weber T, Petrelli NJ (1997) Anal canal and perianal epidermoid cancers. J Am Coll Surg 5:494–505CrossRef Fuchshuber PR, Rodriguez-Bigas M, Weber T, Petrelli NJ (1997) Anal canal and perianal epidermoid cancers. J Am Coll Surg 5:494–505CrossRef
6.
go back to reference Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, Carter JJ, Porter PL, Galloway DA, McDougall JK (2004) Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2:270–280CrossRef Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, Carter JJ, Porter PL, Galloway DA, McDougall JK (2004) Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2:270–280CrossRef
7.
go back to reference Ries LAG, Harkins D, Krapcho M et al (eds) (2005) SEER Cancer Statistics Review, 1975–2003. National Cancer Institute, Baltimore, pp 1–103 Ries LAG, Harkins D, Krapcho M et al (eds) (2005) SEER Cancer Statistics Review, 1975–2003. National Cancer Institute, Baltimore, pp 1–103
8.
go back to reference Stoker J (ed) (2010) Magnetic resonance imaging of the gastrointestinal tract. Springer Verlag, Berlin, Germany Stoker J (ed) (2010) Magnetic resonance imaging of the gastrointestinal tract. Springer Verlag, Berlin, Germany
9.
go back to reference Ryan DP, Mayer RJ (2000) Anal carcinoma: histology, staging, epidemiology, treatment. Curr Opin Oncol 4:345–352CrossRef Ryan DP, Mayer RJ (2000) Anal carcinoma: histology, staging, epidemiology, treatment. Curr Opin Oncol 4:345–352CrossRef
10.
go back to reference Glynne-Jones R, Northover J, Oliveira J, ESMO Guidelines Working Group (2009) Anal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(Suppl 4):57–60. doi:10.1093/annonc/mdp129 PubMed Glynne-Jones R, Northover J, Oliveira J, ESMO Guidelines Working Group (2009) Anal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(Suppl 4):57–60. doi:10.​1093/​annonc/​mdp129 PubMed
11.
go back to reference Glynne-Jones R, Northover JM, Cervantes A, ESMO Guidelines Working Group (2010) Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v87–v92. doi:10.1093/annonc/mdq171 CrossRefPubMed Glynne-Jones R, Northover JM, Cervantes A, ESMO Guidelines Working Group (2010) Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v87–v92. doi:10.​1093/​annonc/​mdq171 CrossRefPubMed
12.
13.
go back to reference Parikh J, Shaw A, Grant LA, Schizas AM, Datta V, Williams AB, Griffin N (2011) Anal carcinomas: the role of endoanal ultrasound and magnetic resonance imaging in staging, response evaluation and follow-up. Eur Radiol 4:776–785. doi:10.1007/s00330-010-1980-7 CrossRef Parikh J, Shaw A, Grant LA, Schizas AM, Datta V, Williams AB, Griffin N (2011) Anal carcinomas: the role of endoanal ultrasound and magnetic resonance imaging in staging, response evaluation and follow-up. Eur Radiol 4:776–785. doi:10.​1007/​s00330-010-1980-7 CrossRef
14.
go back to reference Otto SD, Lee L, Buhr HJ, Frericks B, Höcht S, Kroesen AJ (2009) Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging. J Gastrointest Surg 7:1292–1298. doi:10.1007/s11605-009-0870-2 CrossRef Otto SD, Lee L, Buhr HJ, Frericks B, Höcht S, Kroesen AJ (2009) Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging. J Gastrointest Surg 7:1292–1298. doi:10.​1007/​s11605-009-0870-2 CrossRef
15.
go back to reference Koh DM, Dzik-Jurasz A, O’Neill B, Tait D, Husband JE, Brown G (2008) Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation. Br J Radiol 962:91–98. doi:10.1259/bjr/96187638 CrossRef Koh DM, Dzik-Jurasz A, O’Neill B, Tait D, Husband JE, Brown G (2008) Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation. Br J Radiol 962:91–98. doi:10.​1259/​bjr/​96187638 CrossRef
18.
go back to reference Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual (ed 7th Edition). Springer, New York Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual (ed 7th Edition). Springer, New York
19.
go back to reference Sobin LH, Gospodarowicz MK, Wittekind C (Eds) (2010) TNM Classification of Malignant Tumours (Uicc International Union Against Cancer) (7th Edition) Sobin LH, Gospodarowicz MK, Wittekind C (Eds) (2010) TNM Classification of Malignant Tumours (Uicc International Union Against Cancer) (7th Edition)
20.
go back to reference Goldman S, Auer G, Erhardt K, Seligson U (1987) Prognostic significance of clinical stage, histologic grade, and nuclear DNA content in squamous-cell carcinoma of the anus. Dis Colon Rectum 6:444–448CrossRef Goldman S, Auer G, Erhardt K, Seligson U (1987) Prognostic significance of clinical stage, histologic grade, and nuclear DNA content in squamous-cell carcinoma of the anus. Dis Colon Rectum 6:444–448CrossRef
21.
go back to reference Roohipour R, Patil S, Goodman KA, Minsky BD, Wong WD, Guillem JG, Paty PB, Weiser MR, Neuman HB, Shia J, Schrag D, Temple LK (2008) Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum 2:147–153. doi:10.1007/s10350-007-9125-z CrossRef Roohipour R, Patil S, Goodman KA, Minsky BD, Wong WD, Guillem JG, Paty PB, Weiser MR, Neuman HB, Shia J, Schrag D, Temple LK (2008) Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum 2:147–153. doi:10.​1007/​s10350-007-9125-z CrossRef
22.
go back to reference Das P, Bhatia S, Eng C, Ajani JA, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Bhosale P, Delclos ME, Krishnan S, Janjan NA, Crane CH (2007) Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 3:794–800CrossRef Das P, Bhatia S, Eng C, Ajani JA, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Bhosale P, Delclos ME, Krishnan S, Janjan NA, Crane CH (2007) Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 3:794–800CrossRef
23.
go back to reference Glynne-Jones R, Meadows H, Wan S, Gollins S, Leslie M, Levine E, McDonald AC, Myint S, Samuel L, Sebag-Montefiore D, National Cancer Research Institute Anal Sub Group and Colorectal Clinical Oncology Group (2008) EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer. Int J Radiat Oncol Biol Phys 1:119–126. doi:10.1016/j.ijrobp.2007.12.012 CrossRef Glynne-Jones R, Meadows H, Wan S, Gollins S, Leslie M, Levine E, McDonald AC, Myint S, Samuel L, Sebag-Montefiore D, National Cancer Research Institute Anal Sub Group and Colorectal Clinical Oncology Group (2008) EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer. Int J Radiat Oncol Biol Phys 1:119–126. doi:10.​1016/​j.​ijrobp.​2007.​12.​012 CrossRef
24.
go back to reference Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 5:2040–2049 Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 5:2040–2049
25.
go back to reference UK Co-ordinating Committee on Cancer Research (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. Lancet 9034:1049–1054 UK Co-ordinating Committee on Cancer Research (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. Lancet 9034:1049–1054
26.
go back to reference Touboul E, Schlienger M, Buffat L, Lefkopoulos D, Pène F, Parc R, Tiret E, Gallot D, Malafosse M, Laugier A (1994) Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients. Cancer 6:1569–1579CrossRef Touboul E, Schlienger M, Buffat L, Lefkopoulos D, Pène F, Parc R, Tiret E, Gallot D, Malafosse M, Laugier A (1994) Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients. Cancer 6:1569–1579CrossRef
27.
go back to reference Schlienger M, Krzisch C, Pene F, Marin JL, Gindrey-Vie B, Mauban S, Barthelemy N, Habrand JL, Socie G, Parc R et al (1989) Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases. Int J Radiat Oncol Biol Phys 6:1141–1151CrossRef Schlienger M, Krzisch C, Pene F, Marin JL, Gindrey-Vie B, Mauban S, Barthelemy N, Habrand JL, Socie G, Parc R et al (1989) Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases. Int J Radiat Oncol Biol Phys 6:1141–1151CrossRef
28.
go back to reference Myerson RJ, Kong F, Birnbaum EH, Fleshman JW, Kodner IJ, Picus J, Ratkin GA, Read TE, Walz BJ (2001) Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. Radiother Oncol 1:15–22CrossRef Myerson RJ, Kong F, Birnbaum EH, Fleshman JW, Kodner IJ, Picus J, Ratkin GA, Read TE, Walz BJ (2001) Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. Radiother Oncol 1:15–22CrossRef
29.
go back to reference Constantinou EC, Daly W, Fung CY, Willett CG, Kaufman DS, DeLaney TF (1997) Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys 3:651–657CrossRef Constantinou EC, Daly W, Fung CY, Willett CG, Kaufman DS, DeLaney TF (1997) Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys 3:651–657CrossRef
30.
go back to reference Klas JV, Rothenberger DA, Wong WD, Madoff RD (1999) Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 8:1686–1693CrossRef Klas JV, Rothenberger DA, Wong WD, Madoff RD (1999) Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 8:1686–1693CrossRef
31.
go back to reference Gerard JP, Ayzac L, Hun D, Romestaing P, Coquard R, Ardiet JM, Mornex F (1998) Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients. Radiother Oncol 3:249–256CrossRef Gerard JP, Ayzac L, Hun D, Romestaing P, Coquard R, Ardiet JM, Mornex F (1998) Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients. Radiother Oncol 3:249–256CrossRef
32.
go back to reference Brown G, Richards CJ, Bourne MW, Newcombe RG, Radcliffe AG, Dallimore NS, Williams GT (2003) Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 2:371–377CrossRef Brown G, Richards CJ, Bourne MW, Newcombe RG, Radcliffe AG, Dallimore NS, Williams GT (2003) Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 2:371–377CrossRef
33.
go back to reference Chapet O, Gerard JP, Riche B, Alessio A, Mornex F, Romestaing P (2005) Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer. Int J Radiat Oncol Biol Phys 5:1316–1324CrossRef Chapet O, Gerard JP, Riche B, Alessio A, Mornex F, Romestaing P (2005) Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer. Int J Radiat Oncol Biol Phys 5:1316–1324CrossRef
34.
go back to reference Goh V, Gollub FK, Liaw J, Wellsted D, Przybytniak I, Padhani AR, Glynne-Jones R (2010) Magnetic resonance imaging assessment of squamous cell carcinoma of the anal canal before and after chemoradiation: can MRI predict for eventual clinical outcome? Int J Radiat Oncol Biol Phys 3:715–721. doi:10.1016/j.ijrobp.2009.08.055, Epub 2010 Feb 18CrossRef Goh V, Gollub FK, Liaw J, Wellsted D, Przybytniak I, Padhani AR, Glynne-Jones R (2010) Magnetic resonance imaging assessment of squamous cell carcinoma of the anal canal before and after chemoradiation: can MRI predict for eventual clinical outcome? Int J Radiat Oncol Biol Phys 3:715–721. doi:10.​1016/​j.​ijrobp.​2009.​08.​055, Epub 2010 Feb 18CrossRef
35.
go back to reference Roach SC, Hulse PA, Moulding FJ, Wilson R, Carrington BM (2005) Magnetic resonance imaging of anal cancer. Clin Radiol 10:1111–1119CrossRef Roach SC, Hulse PA, Moulding FJ, Wilson R, Carrington BM (2005) Magnetic resonance imaging of anal cancer. Clin Radiol 10:1111–1119CrossRef
Metadata
Title
The Role of MRI in the Assessment of the Local Status of Anal Carcinomas and in Their Management
Authors
É. Jederán
J. Lővey
Z. Szentirmai
E. Hitre
G. Léránt
K. Horváth
M. Gődény
Publication date
01-07-2015
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 3/2015
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-014-9857-8

Other articles of this Issue 3/2015

Pathology & Oncology Research 3/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine